Centers for Disease Control and Prevention (CDC)
Also known as: CDC and BOTUSA | CDC-Arctic Investigations Program | CDC, Atlanta, GA | CDC/KEMRI | CDC/NCID/DPD | Centers for Diseaes Control and Prevention | Centers for Disease Control and Prevention | Centers for Disease Control and Prevention (bgw2@cdc.gov; bgweniger@siamlotus.com) | Centers for Disease Control & Prevention | Centers for Disease Control (USA) | Immunization Safety Office, Centers for Disease Control and Prevention | National Institute for Occupational Safety and Health (NIOSH/CDC) | New York Center for Travel and Tropical Medicine | US CDC | U.S. Centers for Disease Control and Prevention | U.S. Centers for Disease Control and Prevention (CDC), Atlanta, USA.
Highest phase reached
Phase 4
First clinical trial
Jun 1, 1973Last known activity
Nov 12, 2025
Timeline
1940s
- Jul 1, 1942
Centers for Disease Control and Prevention (CDC)— Founded
Drugs by trial phase (197 distinct, 290 trials)
Phase 4 (82 own, 0 via acquisition)
Phase 3 (54 own, 0 via acquisition)
Phase 2 (24 own, 0 via acquisition)
Phase 1 (17 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Anemia, Iron-Deficiency
- Anthrax
- Apnea
- Asthma
- Atherosclerosis
- Bacteremia
- Birth Weight
- Cardiovascular Diseases
- Chickenpox
- Cholera
- Chorioamnionitis
- Clostridium Infections
- Communicable Diseases
- Condylomata Acuminata
- Coronary Disease
- Cross Infection
- Cryptococcosis
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diarrhea
- Diphtheria
- Drug-Related Side Effects and Adverse Reactions
- Emergencies
- Encephalitis
- Encephalitis, Japanese
- Extensively Drug-Resistant Tuberculosis
- Fever
- Gastroenteritis
- Glucosephosphate Dehydrogenase Deficiency
- Gonorrhea
- Heart Diseases
- Hemorrhagic Fever, Ebola
- Hemorrhagic Fevers, Viral
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Herpes Simplex
- Herpesviridae Infections
- Herpes Zoster
- HIV Infections
- HIV Seropositivity
- Hypercholesterolemia
- Infant, Newborn, Diseases
- Infarction
- Infections
- Influenza, Human
- Influenza in Birds
- Injection Site Reaction
- Intestinal Diseases
- Intussusception
- Ischemia
- Latent Tuberculosis
- Malaria
- Malaria, Falciparum
- Malaria, Vivax
- Measles
- Meningitis
- Meningitis, Cryptococcal
- Motion Sickness
- Mpox, Monkeypox
- Multiple Chronic Conditions
- Myocardial Infarction
- Myocardial Ischemia
- Nodding Syndrome
- Onchocerciasis
- Opportunistic Infections
- Paratyphoid Fever
- Perinatal Death
- Plague
- Pneumococcal Infections
- Pneumonia
- Poliomyelitis
- Premature Birth
- Puerperal Infection
- Respiratory Sounds
- Respiratory Tract Infections
- Rotavirus Infections
- Rubella
- Rubella Syndrome, Congenital
- Seizures
- Seizures, Febrile
- Sepsis
- Smallpox
- Sprue, Tropical
- Stillbirth
- Syndrome
- Syphilis
- Tetanus
- Trichomonas Vaginitis
- Tuberculosis
- Tuberculosis, Multidrug-Resistant
- Tuberculosis, Pulmonary
- Typhoid Fever
- Ulcer
- Urinary Tract Infections
- Uterine Cervical Neoplasms
- Vaccinia
- Vaginal Diseases
Recent trials (50)
- NCT07287137CollaboratorPhase 4Nov 12, 2025
- NCT07158814CollaboratorPhase 4Oct 2, 2025
- NCT06895486CollaboratorPhase 2Sep 29, 2025
- NCT06962904Lead sponsorPhase 1Jul 7, 2025
- NCT07082205CollaboratorPhase 3May 2, 2025
- NCT06590675CollaboratorN/AJan 31, 2025
- NCT06618534CollaboratorPhase 2Oct 31, 2024
- NCT06321536CollaboratorPhase 2Oct 31, 2024
- NCT06545656CollaboratorPhase 4Sep 13, 2024
- NCT06503900OfficialPhase 4Sep 12, 2024
- NCT06518577CollaboratorPhase 4Sep 9, 2024
- NCT06485258Lead sponsorPhase 1Aug 5, 2024
- NCT06274398CollaboratorPhase 1Jan 16, 2024
- NCT06274398OfficialPhase 1Jan 16, 2024
- NCT06165354CollaboratorN/ADec 31, 2023
Details
- Founded
- Atlanta, GA, US Jul 1, 1942
- Last known activity
- Nov 12, 2025